Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.

Autor: Korotych O; Division of Communicable Diseases, Environment, and Health, WHO Regional Office for Europe, Copenhagen, Denmark. Electronic address: korotycho@who.int., Achar J; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden; Department for Science and Innovation-National Research Fund Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Gurbanova E; Lung Clinic, University of Tartu, Tartu, Estonia., Hovhannesyan A; Division of Communicable Diseases, Environment, and Health, WHO Regional Office for Europe, Copenhagen, Denmark., Lomtadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia; The University of Georgia, Tbilisi, Georgia., Ciobanu A; Division of Communicable Diseases, Environment, and Health, WHO Regional Office for Europe, Copenhagen, Denmark., Skrahina A; The Republican Scientific and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus., Dravniece G; PATH, Kyiv, Ukraine., Kuksa L; TB and Lung Disease Clinic, Riga East University Hospital, Riga, Latvia., Rich M; Partners In Health, Boston, MA, United States of America., Khachatryan N; National Center of Pulmonology of the Ministry of Health of Armenia, Abovyan, Armenia., Germanovych M; Division of Communicable Diseases, Environment, and Health, WHO Regional Office for Europe, Copenhagen, Denmark; State Institution 'Public Health Center of the Ministry of Health of Ukraine', Kyiv, Ukraine., Kadyrov A; National Center of Phthisiology, Ministry of Health of Kyrgyzstan, Bishkek, Kyrgyzstan., Terleieva I; State Institution 'Public Health Center of the Ministry of Health of Ukraine', Kyiv, Ukraine., Akhundova I; Scientific Research Institute of Lung Diseases, Baku, Azerbaijan., Adenov M; National Scientific Center of Phthisiopulmonology of the Republic of Kazakhstan, Almaty, Kazakhstan., Durdyeva M; Turkmen State Medical University, Ashgabat, Turkmenistan., Kiria N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Parpieva N; Republican Specialized Scientific-Practical Medical Center of Phthisiology And Pulmonology, Ministry of Health, Tashkent, Uzbekistan., Yatskevich N; The Republican Scientific and Practical Center for Pulmonology and Tuberculosis, Minsk, Belarus., Jumayev R; National Tuberculosis Treatment and Prevention Center, Directorate of Communicable Diseases, Ashgabat, Turkmenistan., Nurov R; Republican Center for Protection of the Population from Tuberculosis, Ministry of Health and Social Protection of the Population, Dushanbe, Tajikistan., Diktanas S; Republican Klaipeda Hospital, Tuberculosis Branch, Klaipeda, Lithuania., Vilc V; The Institute of Phthisiopneumology, Chisinau, Republic of Moldova., Migliori GB; Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Tradate, Italy., Yedilbayev A; Division of Communicable Diseases, Environment, and Health, WHO Regional Office for Europe, Copenhagen, Denmark.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Oct; Vol. 24 (10), pp. 1151-1161. Date of Electronic Publication: 2024 Jun 13.

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region.

Autor: Migliori GB; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Tradate, Italy., Korotych O; Joint Infectious Diseases Unit, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Achar J; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; Department of Science and Innovation-National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South Africa Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Ciobanu A; Joint Infectious Diseases Unit, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Dravniece G; PATH, Kyiv, Ukraine., Germanovych M; Joint Infectious Diseases Unit, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Gurbanova E; Lung Clinic, University of Tartu, Tartu, Estonia., Hovhannesyan A; Joint Infectious Diseases Unit, World Health Organization Regional Office for Europe, Copenhagen, Denmark., Khachatryan N; National Center of Pulmonology, Ministry of Health, Abovyan, Armenia., Kuksa L; Tuberculosis and Lung Disease Clinic, Riga East Univesity Hospital, Riga, Latvia., Lomtadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.; The University of Georgia, Tbilisi, Georgia., Rich ML; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Skrahina A; Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Yedilbayev A; Joint Infectious Diseases Unit, World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Publikováno v: IJTLD open [IJTLD Open] 2024 Mar 01; Vol. 1 (3), pp. 103-110. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).

Additional file 3 of Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

Autor: van de Berg, S. E. J., Pelzer, P. T., van der Land, A. J., Abdrakhmanova, E., Ozi, A. Muhammad, Arias, M., Cook-Scalise, S., Dravniece, G., Gebhard, A., Juneja, S., Handayani, R., Kappel, D., Kimerling, M., Koppelaar, I., Malhotra, S., Myrzaliev, B., Nsa, B., Sugiharto, J., Engel, N., Mulder, C., van den Hof, S.

Additional file 3.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db2215d08d03090dbcd7f936fbb746a

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.